Table 3.
Clinical outcomes among NORIN‐STEMI participants, stratified by left ventricular ejection fraction at presentation
| LVEF ≥50% (N = 468, 13%) | LVEF 40–49% (N = 1482, 41%) | LVEF 30–39% (N = 1357, 38%) | LVEF <30% (N = 290, 8%) | |
|---|---|---|---|---|
| In‐hospital mortality | 13 (3%) | 49 (3%) | 81 (6%) | 69 (24%) |
| 30 day all‐cause mortality | 18 (4%) | 80 (6%) | 109 (9%) | 80 (29%) |
| 30 day all‐cause readmission | 8 (2%) | 34 (3%) | 102 (9%) | 93 (49%) |
| 30 day heart failure readmission | 3 (1%) | 23 (2%) | 92 (7%) | 83 (38%) |
| 1 year all‐cause mortality | 31 (7%) | 120 (8%) | 154 (11%) | 95 (33%) |
30 day and 1 year outcomes are calculated as days from discharge.